MENU
AVTE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aerovate Therapeutics (AVTE) Ownership - Who owns Aerovate Therapeutics?
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease... Show more
Profile
Industry
N/A
Address
930 Winter Street
Phone
+1 617 443-2400
Employees
51
Web
https://www.aerovatetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
73.04M
P/E Ratio
N/A
Total Cash
88.73M
Projected Growth
N/A
Total Debt
540K
Revenue
N/A
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash/Share
3.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AVTE
Capitalization
73M
P/E Ratio
N/A
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash
88.7M
Total Cash/Share
3.06
Total Debt
540K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
80.5M
P/B Ratio
0.96
Cash Flow
N/A
Earnings
-2.99
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
8.78
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-89.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-72.99
Shares Held By Institutions
81.6M
Shares Outstanding - Current
29M
Total Liabilities
10.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-5.283
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
930 Winter Street
Phone
+1 617 443-2400
Employees
51
Web
https://www.aerovatetx.com